FDA advisors recommend replacing original COVID-19 vaccine, CNBC reports

The Food and Drug Administration’s, FDA, independent advisory committee recommended replacing Pfizer (PFE) and Moderna’s (MRNA) original COVID vaccine used in the U.S. for the first two immunization shots with the new bivalent omicron shots, Spencer Kimball of CNBC reports. If this recommendation is accepted by the FDA, the U.S. would likely phase out the original vaccines developed in 2020 against the original COVID-19 strain and instead use the drugmakers’ bivalent omicron shots that target the omicron BA.5 variant as well as the original strain for the entire vaccination series. Currently, Pfizer and Moderna’s omicron shots are only authorized as a booster shot. The independent advisory committee’s 21 member unanimously back the proposal. Reference Link